frequency, nasal obstruction) were recorded before challenge and every 15 minutes after challenge initiation. For the evaluation of nasal obstruction, we used visual analog scales (VASs); subjects marked a site on a 10-cm line corresponding to the symptom severity on which absence of symptoms was designated as 0 and worst imaginable symptom as 10. PIFR was measured using an In-check flow meter and nasal resistance was measured using Rhino. The cross-sectional area in the nasal cavity was also measured using AR before and after challenge as an indicator of nasal obstruction. Results: When the volunteers with cedar pollinosis were exposed to cedar pollen in ACC, pollinosis symptoms were induced significantly. Changes in the 3 symptoms (sneezing frequency, nose-blowing frequency, nasal obstruction) were investigated before and after challenges on 2 consecutive days. No significant symptoms were induced on the first day of challenge in the non-pollen season. However, each of the 3 symptoms became more severe with second day of challenge, and a significant increase was seen in cumulative values by the second day. In terms of the allergen challenge test, we found a significant correlation between nasal obstruction symptom (VAS) and PIFR, but not AR and Rhino. Conclusions: PIFR after allergen challenge is more sensitive than AR or Rhino in detecting nasal obstruction using the allergen challenge chamber.
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Nasal Poliposis and Allergic Disease. Dr. Salvador Allende Hospital Ada Castillo Méndez, MD. Alergia, MINSAP, Habana, Cuba. Background: The edematous irritation of the corium of the pituitary mucosa wakes it suffers a degeneration that causes what is known as nasal polyposis, hypertrophy of the nasal mucosa as a result of a chronic inflamatory process. It is said that its formation is due to infectious processes, vascular changes as local disorders of the immunity of the nasal mucosa. However many concide in including the allergic factors as the cause of the nasal polypos and they give a special interest to the constitutional factor inside the genesis of them. The investigation had as objectives to know the relationship that there is between the nasal polyposis and the allergic diseases, as well as to study some parameters of the humoral and celular immunity in our patients. Methods: 15 patients diagnosed wiht nasal polyposis were taken from the otorhinolaryngologists and they were sent to the allergic department to be evaluated. Patient's charts of all of thems were made and they were indicated some studies such as eosinophil global count, nasal exudate,sample radiographic study of paranasal sinus, serology, hemogram, glycemia and minimal clotting test, study of the humoral immunity and making determination of IgE, IgA, IgG, IgM. The celular immunity was also studied by making a determination of active and expontaneous Roseta test. And a life evaluation was made too by means of the hypersensitivity retard tests. Results: High figures of elevated IgE were obtained in a 67 % of the patients studied. A control group was made for the Igs determination and the Roseta test. No significant difference was found in the Roseta test. Conclusions: The elevation of the IgE in the patients studied makes us infer that there is an evident relation ship between these 2 pathologies. There is no evidence. That shows that there is an alteration of the celular immunity in the sample of the patients with nasal polyposis that were studied. Background: CT navigation is an assistant tool for identification and location of anatomical structures during surgery based on computer processed preoperative CT images followed by registration. CT navigation facilitates exact localization of particular anatomical points and at the same time also allows determination of the exact position of a respective instrument in 3D pictures and in 3 CT planes. Methods: The optical CT navigation system Treon Plus (Medtronic-Xomed) is successfully being used at the ENT Department of the 3 rd Medical Faculty Charles University and Central Military Clinic, Prague, Czech Republic. We studied the advantages of CT navigation use on 141 patients (257 procedures) operated from January, 1, 2007 till December, 31, 2009 . The CT navigation was used for primary sinus endoscopic surgery (81 procedures), revision sinus endoscopic surgery (46), surgical treatment of injuries (7), and in tumors (7). We examined the use of optical CT navigation with MRI fusion for delimitation of extensive tumor of the tongue. Results: In operated group of patients we observed no major per-or postoperative complications. Conclusions: The primary benefit of the presented CT navigation is the feasibility of higher radicality, accuracy, together with delicacy towards the surrounding tissues. This work was supported by grant 0801 8 8030 from the Ministry of Defence, Czech Republic. 3 University of Montpellier, Montpellier, France. Background: To assess the methodological rigour and transparency of reporting in clinical practice guidelines for the management of allergic rhinitis (AR). Methods: We systematically searched MEDLINE, TRIP database (including the National Guidelines Clearinghouse) and professional society websites for guidelines about the management of AR published after the year 2000. We assumed that older guidelines would no longer influence current clinical practice. If the guideline was updated after 2000 we assessed the most recent version. We included all guidelines published in English and endorsed by an international or national government agency or professional group, irrespective of country of origin or publication status. Two reviewers independently screened search results using predefined eligibility criteria and assessed the rigour of development and reporting of included guidelines using the AGREE II instrument (www.agreetrust.org). Results: Our search revealed 432 records of which 34 full text articles were assessed for eligibility. Nine documents fulfilled our criteria-3 international and 6 national guidelines from Japan, Singapore, South Africa, UK and the USA. Overall methodological rigour and reporting of guidelines about the management of AR was variabledfrom fulfilling most AGREE II criteria to almost none. There was no association between the methodological rigour and time of publication or the target scope of the guideline (national versus international). Across all guidelines the most rigorously reported domain was "clarity of presentation" (median score 53%), mainly due to fair presentation of different management options (item 16), followed by "scope and purpose" (median score 42%). The least rigorously addressed was "applicability" domain with median score of 2% across all guidelines. Median scores for domains "stakeholder involvement", "rigour of development" and editorial independence" were 17%, 15% and 25%, respectively. The ARIA guidelines (2010 update) achieved the highest scores in 5 out of 6 domains and the lowest score on any domain was 60%. Conclusions: Guideline users should be aware of the variability in quality of development and reporting of guidelines for the management of AR. They should choose higher quality guidelines to inform their practice. For many guidelines there is much room for improvement, in particular in the domains of applicability and implementation. Objective: To determine prognostic value of acoustic rhinometry in patients with perennial allergic rhinitis (PAR) treated with montelukast in fix combination with desloratidine and to assess effectiveness of this medication on health-related quality of life (HRQL). Study design: A randomized, double-blind, prospective and multicentric clinical study. Setting: Tertiary university hospitals. Methods: Patients 20 years of age and older with PAR were assessed over 3 months of treatment with fix combination of montelukast 10 mg plus desloratidine 5 mg once daily (n ¼ 40). Comparative acoustic rhinometric evaluation was used to compare nasal changes in before and after treatments. For evaluation of HRQL between before and after treatments at the first and third months, the Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) was used. Results: Nasal symptoms and findings including itching, sneezing, discharge, congestion and edema and color change of turbinates have been decreased after treatment. In acoustic rhinometry, minimum cross-sectional area (MCA) measurements and volume results were statistically higher than in before treatment (P , 0.001). Correlation was found that between the volume results and nasal discharged and/or congestion in right nasal passages. In left nasal passages, statistical relation was described between the MCA measurements and itching and/or change of turbinate color (P , 0.05). There was a larger decrease in the overall RQLQ score for the group using montelukast plus desloratidine compared with the pre-treatment scores (P , 0.001). The difference between scores at baseline versus the end of the first and third months for all domains was statically significant (P , 0.001). The treatment difference in change from first month to the end of the third month was statically significant, in favor of the third month, for eye, nose, and non-nose/eye symptoms, sleep, practical problems, emotions and activities that have been limited by nose or eye symptoms, and for overall score. Conclusions: Significant reductions in signs and symptoms of PAR with montelukast plus desloratadine treatment were accompanied by improved disease-specific QOL measures. Montelukast in combination with desloratidine provides improvements in acoustic rhinometric values including volume and MCA in patients with PAR. Acoustic rhinometry should be use in diagnostic and prognostic process in patients with PAR.
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HLA-B58 Does not Increase Allopurinol Hypersensitivity among Patients with Hematologic Malignancy
Jae-Woo Jung, Min-Hye Kim, Woo-Jung Song, Tae-Wan Kim, So-Hee Lee, Sae-Hoon Kim, Hye-Ryun Kang, Heung-Woo Park, Sun-Sin Kim, YoonSeok Chang, MD, PhD, Sang-Heon Cho, and Kyung-Up Min. Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea. Background: HLA-B58 is a very strong marker of allopurinol-induced severe cutaneous adverse reactions (SCARs), especially in population with high frequency of HLA-B58, such as Chinese, Thai, and Korean. Although allopurinol is frequently prescribed to patients receiving chemotherapy for the prevention of tumor lysis syndrome, the risk of allopurinol-related SCARs in patients with hematologic malignancies is not evaluated. This study was conducted to find out the incidence of allopurinol-induced hypersensitivity in patients with hematologic malignancy during chemotherapy according to HLA-B58 and clinical usefulness of HLA-B58 as a risk marker for the development of allopurinol-induced hypersensitivity. Methods: We retrospectively reviewed the medical records of patients with hematologic malignancy who ever took allopurinol and underwent serologic HLA typing for bone marrow transplantation from January 2000 to May 2010. Results: Among total 463 patients, 13 (2.8%) patients experienced allopurinol hypersensitivity reactions which were simple maculopapular rash and none of those were compatible with SCARs. The mean duration of allopurinol exposure in total patients was 26.46 days (1w2,173) and the mean duration until development of rash was 5.54 6 1.20 days. Fifty patients (10.8%) had HLA-B58. However, the incidence of allopurinol induced rash was not different according to HLA-B58 (4% (2/50) and 2.66% (11/413) in B58 (1) and B58 (-) patients, respectively). Frequency of B58 was slightly higher in patients with rash (15.4%) compared with tolerant patients (10.7%) but the difference was statistically insignificant (P . 0.05).
Conclusions:
The results of this study that HLA-B58 does not increase the risk of allopurinol induced SCARs as well as simple rash among patients with hematologic malignancy. Allopurinol can be used safely in most patients with hematologic malignancy during chemotherapy and HLA typing does not give additional advantage for clinical decision. Objective: Identify risk factors associated to mortality in pediatric patients with hemophagocytic lymphohistiocytosis. Methods: Retrospective cross-sectional study of medical records with discharge diagnosis of Hemophagocytic syndrome/Hemophagocytic lymphohistiocytosis (ICD-10; D76.1/D76.2) from Jan2004-May2011 in a pediatrictertiary-care-center. Descriptive and risk analysis were made on SPSS Statistics V17.0. Results: Thirty medical records were analyzed. Median-for-age: 2 years 8 months, (range: 2 months-to-15 years). Sex distribution: 14 girls (47%), 16 boys (53%). Median of symptoms duration: 1 month (range: 3 days-to-7 years). Reported symptoms and physical signs at hospital admission: fever n ¼ 28 (93%), asthenia/adynamia n ¼ 11 (37%), skin findings n ¼ 10 (33%), epistaxis n ¼ 5 (17%), gastrointestinal bleeding n ¼ 4 (13%), hepatomegaly n ¼ 27 (90%), splenomegaly n ¼ 21 (70%), lymphadenopathies n ¼ 14 (47%), paleness n ¼ 14 (47%), purpura n ¼ 5 (17%). Laboratory findings: anemia n ¼ 29 (97%), LDH elevation n ¼ 28 (93%), hypoalbuminemia n ¼ 27 (90%), thrombocytopenia n ¼ 26 (87%), hypertransaminasemia n ¼ 25 (83%), haemophagocytosis n ¼ 22 (73%), hypertrigliceridemia n ¼ 21 (70%), hypofibrinogenemia n ¼ 20 (67%), leucopenia n ¼ 19 (63%), hyperferritinemia n ¼ 15 (50%). In 18 patients (60%) active infection was evident at hospital admission: pneumonia n ¼ 9(50%), gastroenteritis n ¼ 2 (11%), meningitis n ¼ 1 (5%), others n ¼ 6 (33%). Epstein-Barr virus infection was diagnosed in 7 patients (23%). All patients were treated according to HLH-2004 guidelines. 
